molecular interactions

Schrödinger CEO Discusses Physics-Driven AI for Drug Discovery

Schrödinger's CEO discusses the company's innovative approach to using physics in AI-driven drug discovery. By integrating advanced computational methods, they aim to enhance the efficiency and effectiveness of developing new medications, potentially transforming the pharmaceutical industry.